Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Awarded

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
253
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Awarded Full Depository Trust Company Eligibility

- Phivida has been awarded DTC and CNS eligibility for its common shares
- Company is a premium food and beverage leader in the use of infused cannabinoids
- Phivida’s mission is to help lessen the world’s dependence on pharmaceuticals

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium functional food and beverage business based in Vancouver, British Columbia. The company infuses all of its products with organic cannabinoids from hemp, and it offers premium beverages and clinical products for everyday health.

Phivida recently announced that it has been awarded full DTC (Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for its common shares listed for trading on the OTCQX® Best Market under the symbol “PHVAF” in the U.S. (http://nnw.fm/Py9Lz).

DTC’s emphasis is worldwide trading activity. It processes trillions of dollars of securities transactions daily. DTC provides an electronic process of clearing securities that expedites the receipt of stock and cash while speeding up the settlement process. CNS is an automated book-entry accounting system. Its focus is on centralizing the settlement of security transactions. It does so while maintaining an organized flow of security and money balances between those participating in the market.

Phivida’s expectation is that achieving DTC and CNS eligibility will simplify and fast-track settlement for investors while boosting the liquidity of its common shares on the OTC Market. CNS eligibility ensures that all DTC eligible trades and cash balances are centralized, cleared and settled in an efficient and systematic way.

Regarding its business, Phivida’s belief is that overall body health and balance are best maintained through whole plant nutrition and natural ingredients. Phivida sources its products from premier organic hemp and natural ingredients. These products are third-party lab tested for quality, purity and potency at world-class facilities. Hemp is a source of full-spectrum cannabinoids and is high CBD/low THC.

Phivida’s product line-up includes beverages, capsules and tinctures. Oki is its newest brand of hemp extract-infused flavored iced teas, flavor-infused waters and tinctures and capsules. In addition, the company offers the Vida+ line of premium hemp-infused products, including hemp oil extract and hemp oil capsules.

Phivida is cGMP-compliant (Current Good Manufacturing Practice) to ensure pharmaceutical quality. The company fuses ancient eastern traditions of whole plant medicine with contemporary western principles of naturopathic science. Phivida employs encapsulation technology. It converts phytocannabinoids into a water-soluble delivery format. This format improves bioavailability and timed released within the body.

Recently, Phivida signed an agreement with Acosta’s National Specialty Sales division, which gives the company access to 2,400 national specialty retailers throughout the United States.

Moreover, Phivida and WeedMD (OTC: WDDMF) have signed a final definitive Joint Venture (JV) agreement. This agreement is to develop and operate Cannabis Beverages, Inc. (CanBev), with each company retaining 50 percent of the Class A shares in CanBev.

For more information, visit the company’s website at www.Phivida.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Phivida Holdings Inc. (PHVAF) Stock Research Links

PHVAF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 74

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 37

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 113

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 275

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 407

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Daniel Pink on Leadership and Workplace Evolution Insights

Updated Category News Views 424

Exploring Leadership in a Changing Workplace The recent episode of Info-Tech Research Group's podcast, Digital Disruption, highlights a thought-provoking discussion with bestselling author Daniel Pink, focusing on how leaders can adapt in a time he describes as 'the great sort'. This term encapsulates the ongoing transformation in our approach to work, leadership, and the...

Continue Reading
MORSE Corp's Community Cleanup Initiative: Making an Impact

Updated Category News Views 240

MORSE Corp's Commitment to Community Service MORSE Corp recently dedicated an entire day to community service by hosting a cleanup initiative at local beaches and parks. On a beautiful Wednesday, the organization mobilized its team to gather at a coastal spot to improve the environment and promote community spirit. This initiative is part of their annual effort to...

Continue Reading
FDA's New Proposal to Enhance Nutrition Awareness on Food Labels

Updated Category News Views 125

Revolutionizing Nutrition Transparency for Consumers Today, the U.S. Food and Drug Administration (FDA) is taking significant steps towards improving consumer awareness about the nutritional value of packaged foods. A new proposal dictates that most packaged foods will require a prominent front-of-package (FOP) nutrition label. This initiative is part of a broader...

Continue Reading
CW Bancorp Declares Quarterly Dividend for Shareholders

Updated Category News Views 150

CW Bancorp Announces Dividend Declaration CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, has approved a quarterly cash dividend. The news comes as the company continues to prioritize shareholder value while supporting its growth journey. Details of the Cash Dividend The Board of Directors of CW Bancorp declared a cash dividend of $0.23 per common...

Continue Reading
Universal Electronics Unveils QuickSet homeSense at CES Event

Updated Category News Views 348

Universal Electronics Introduces QuickSet homeSense Technology Universal Electronics Inc. (NASDAQ: UEIC) has made headlines by launching its innovative QuickSet homeSense technology. This introduction took place at the prestigious International Consumer Electronics Show (CES) where the spotlight is often on groundbreaking tech. UEI, a leader in wireless control solutions,...

Continue Reading